Field Randomization of NA-1 Therapy in Early Responders "FRONTIER"

Recruiting

Phase 3 Results N/A

Summary of Purpose

The purpose of this study is to determine whether NA-1 is effective in reducing global disability in patients with acute cerebral ischemia if administered early after symptom onset.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 April 2018.

26 Mar 2015 5 Dec 2014 31 Mar 2020 31 Mar 2020 1 Apr 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

See All